Mesa Laboratories
MLAB
A$118.42
Share price
2.17%
Change (1 day)
-28.43%
Change (1 year)
Categories
Mesa Laboratories (MLAB) - Total debt
Total debt on the balance sheet as of March 2025 : A$0.27 Billion
According to Mesa Laboratories's latest financial reports the company's total debt is A$0.27 Billion. A company’s total debt is the sum of all current and non-current debts.
Mesa Laboratories - Total debt on balance sheet (from 2010 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-03-31 | A$0.34 B | 23.74% |
| 2023-03-31 | A$0.27 B | -5.84% |
| 2022-03-31 | A$0.29 B | 52.8% |
| 2021-03-31 | A$0.19 B | -16.14% |
| 2020-03-31 | A$0.23 B | 620.72% |
| 2019-03-31 | A$31.96 M | -46.92% |
| 2018-03-31 | A$60.21 M | -15.99% |
| 2017-03-31 | A$71.67 M | 21.48% |
| 2016-03-31 | A$58.99 M | 71.12% |
| 2015-03-31 | A$34.47 M | 93.67% |
| 2014-03-31 | A$17.8 M | 363.4% |
| 2013-03-31 | A$3.84 M | |
| 2011-03-31 | A$6.28 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | A$52.40 B | 18,739.82% | 🇺🇸 USA |
 Ametek AME | A$2.95 B | 964.06% | 🇺🇸 USA |
 Bruker BRKR | A$3.23 B | 1,064.81% | 🇺🇸 USA |
 3M MMM | A$21.56 B | 7,651.61% | 🇺🇸 USA |
 Steris STE | A$3.37 B | 1,113.71% | 🇮🇪 Ireland |
 AngioDynamics ANGO | A$7.66 M | -97.24% | 🇺🇸 USA |
 Danaher DHR | A$25.25 B | 8,979.64% | 🇺🇸 USA |
 Rockwell Medical
RMTI | A$19.72 M | -92.91% | 🇺🇸 USA |
 General Electric GE | A$29.99 B | 10,684.58% | 🇺🇸 USA |